Clinical and Translational Research Unit (CTRU) — Palo Alto, California

Clinical and Translational Research Unit (CTRU) is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Clinical and Translational Research Unit (CTRU) has participated in 6 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Hemophilia B, Hemophilia A.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical and Translational Research Unit (CTRU)?

Clinical and Translational Research Unit (CTRU) has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical and Translational Research Unit (CTRU) conducted?

Clinical and Translational Research Unit (CTRU) has 6 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Hemophilia B, Hemophilia A.

Is Clinical and Translational Research Unit (CTRU) accredited by Crixeo Health?

Clinical and Translational Research Unit (CTRU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical and Translational Research Unit (CTRU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.